Neon Therapeutics
company
About
NEON Therapeutics is focused on unlocking the full potential of the immune system to recognize and attack cancer.
- 101 - 250
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $70M
- Industries
- Bioinformatics,Biotechnology,Health Care,Medical,Therapeutics
- Founded date
- Jan 1, 2015
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Neon Therapeutics is a clinical-stage biopharmaceutical company. It is focused in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens. The company's pipeline products are NEO-PV-01, NEO-PTC-01, and NEO-SV-01.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$106M
Neon Therapeutics has raised a total of
$106M
in funding over 2 rounds. Their latest funding was raised on
Dec 5, 2017 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 5, 2017 | Series B | $36M | 1 | — | — | Detail |
| Jan 5, 2017 | Series B | $70M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Neon Therapeutics is funded by 1 investors.
Inbio Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Inbio Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
